Barnett, R. M., Jang, A., Lanka, S., Fu, P., Bucheit, L. A., Babiker, H., . . . Barata, P. Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers. Nature Portfolio.
Chicago Style (17th ed.) CitationBarnett, Reagan M., et al. Blood-based Tumor Mutational Burden Impacts Clinical Outcomes of Immune Checkpoint Inhibitor Treated Breast and Prostate Cancers. Nature Portfolio.
MLA (9th ed.) CitationBarnett, Reagan M., et al. Blood-based Tumor Mutational Burden Impacts Clinical Outcomes of Immune Checkpoint Inhibitor Treated Breast and Prostate Cancers. Nature Portfolio.
Warning: These citations may not always be 100% accurate.